FDA Head Says OxyContin Was Approved Illegally. Now What?
Martin Makary, commissioner of the Food and Drug Administration, arrives for a senate hearing in Washington on May 22, 2025.
Photographer: Annabelle Gordon/BloombergThis article is for subscribers only.
Hi, it’s Sam in New York. Earlier this year, I wrote about the FDA’s role in igniting the opioid epidemic. More on why this is back in the news in a moment, but first …
Help us improve Bloomberg newsletters: Please take a quick survey to share your thoughts on your sign-up experience and what you’d like to see in the future.